Methacrylic acid-co-butylmethacrylate copolymers: design, characterization and evaluation as encapsulating material for colon targeted formulations

References

• Langholz E. Current trends in inflammatory bowel disease: the natural history. Ther. Adv. Gastroenterol. 2010;3: 77–86.
   PubMedGoogle Scholar
• Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369:1641–1657.10.1016/S0140-6736(07)60751-X
   PubMed Web of Science ®Google Scholar
• Triantafillidis JK, Nasioulas G, Kosmidis PA. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 2009;29:2727–2737.
   PubMed Web of Science ®Google Scholar
• Latella G, Papi C. Crucial steps in the natural history of inflammatory bowel disease. World J. Gastroenterol. 2012;18:3790–3799.10.3748/wjg.v18.i29.3790
   PubMed Web of Science ®Google Scholar
• Munkholm RL Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol. Ther. 18( Suppl. 2):1–5.
   PubMed Web of Science ®Google Scholar
• Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.10.1053/j.gastro.2011.10.001
   PubMed Web of Science ®Google Scholar
• Soon IS, Molodecky NA, Rabi DM, et al. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol. 2012;12:51.10.1186/1471-230X-12-51
   PubMed Web of Science ®Google Scholar
• Li Z, de Zhang K, Yi WQ, et al. NF-κB p65 antisense oligonucleotides may serve as a novel molecular approach for the treatment of patients with ulcerative colitis. Arch. Med. Res. 2008;39:729–734.10.1016/j.arcmed.2008.08.001
   PubMed Web of Science ®Google Scholar
• Oslen T, Cui G, Goll R, et al. Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis. Scand. J. Gastroenterol. 2009;44:727–735.
   PubMed Web of Science ®Google Scholar
• Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53:1–6.10.1136/gut.2004.043372
   PubMed Web of Science ®Google Scholar
• Sandborn WJ. Oral 5-ASA therapy in Ulcerative colitis: what are the implications of the new formulations? J. Clin. Gastroenterol. 2008;42:338–344.10.1097/MCG.0b013e3181595b56
   PubMed Web of Science ®Google Scholar
• Sobczak M, Fabisiak A, Murawska N, et al. Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases. Pharmacol. Rep. 2014;66:766–775.10.1016/j.pharep.2014.04.005
   PubMed Web of Science ®Google Scholar
• Jain NK. Advances in controlled and novel drug delivery. 1st ed. New Delhi: CBS Publishers and Distributors; 2001. p. 89–119.
   Google Scholar
• Jain SK, Jain A. Target-specific drug release to the colon. Expert Opin. Drug Delivery. 2008;5:483–498.10.1517/edd.2008.5.issue-5
   PubMed Web of Science ®Google Scholar
• Nemec JW, Bauer W. Acrylic and methacrylic acid polymers. In: Mark HF, Kroschwitz JL, editors. Encyclopedia of polymer science and engineering. 2nd ed. New York (NY): Wiley; 1985.p. 211–234.
   Google Scholar
• Jones D. Pharmaceutical applications of polymers for drug delivery. In: Rapra review reports. Vol. 15. UK: Rapra Technology Ltd; 2004. p. 3–4.
   Google Scholar
• Thakral SK, Thakral NK, Majumdar DK. Eudragit®: a technology evaluation. Expert Opin. Drug Delivery. 2013;10:131–149.10.1517/17425247.2013.736962
   PubMed Web of Science ®Google Scholar
• Muñoz-Muñoz F, Ruiz JC, Alvarez-Lorenzo C, et al. Novel interpenetrating smart polymer networks grafted onto polypropylene by gamma radiation for loading and delivery of vancomycin. Eur. Polym. J. 2009;45:1859–1867.10.1016/j.eurpolymj.2009.04.023
   Web of Science ®Google Scholar
• Loughlin RG, Tunney MM, Donnelly RF, et al. Modulation of gel formation and drug-release characteristics of lidocaine-loaded poly(vinyl alcohol)-tetraborate hydrogel systems using scavenger polyol sugars. Eur. J. Pharm. Biopharm. 2008;69:1135–1146.10.1016/j.ejpb.2008.01.033
   PubMed Web of Science ®Google Scholar
• Vijay S, Sati OP, Majumdar DK. Acrylic acid–methyl methacrylate copolymer for oral prolonged drug release. J. Mater. Sci.: Mater. Med. 2010;21:2583–2592.
   PubMed Web of Science ®Google Scholar
• Vijay S, Sati OP, Majumdar DK. Acrylic acid–methyl methacrylate (2.5:7.5/2:8) enteric copolymer for targeted drug delivery. J. Mater. Sci.: Mater. Med. 2010; 22:125–135.
   PubMed Web of Science ®Google Scholar
• Kanevskaya YA, Shchepilov AM, Zubov PI. The effect of the supermolecular structure of coatings of a copolymer of butyl methacrylate and methacrylic acid on durability. Polym. Sci. USSR. 1970;12:2201–2206.10.1016/0032-3950(70)90449-1
   Google Scholar
• Konstantinopolskaya MB, Kanevskaya YA, Karyakina MI, et al. The structure of a copolymer of butyl methacrylate and methacrylic acid. Polym. Sci. USSR. 1965:1102–1105.10.1016/0032-3950(65)90386-2
   Google Scholar
• Qui X, Song G, Chu X, et al. microencapsulated n-alkane with p (n-butyl methacrylate-co-methacrylic acid) shell as phase change materials for the thermal energy storage. Solar Energy. 2013;91:212–220.
   Web of Science ®Google Scholar
• Bezuglyi VD, Voskresenskaya IB, Alekseyeva TA, et al. Investigation of the copolymerization of methacrylic acid with methyl acrylate and butyl methacrylate in water–dioxan solvent systems. Polym. Sci. USSR. 1975;17:112–116.10.1016/0032-3950(75)90222-1
   Google Scholar
• Scherrer RA, Whitehouse MW. Anti-inflammatory agents. New York (NY): Academic Press; 1974. p. 33.
   Google Scholar
• Neil MJ, editor. The Merck index: an encyclopedia of chemicals, drugs and biological. 14th ed. Whitehouse station (NJ). Merck Research Laboratories Division of Merck & Co.; 2006. p. 582.
   Google Scholar
• Dooley M, Spencer CM, Dunn CJ. Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. Drugs. 2001;61:1351–1378.10.2165/00003495-200161090-00012
   PubMed Web of Science ®Google Scholar
• Meyer JH, Dressman J, Fink AS, et al. Effect of size and density on gastric emptying of indigestible solids. Gastroenterology. 1985;89:805–813.
   PubMed Web of Science ®Google Scholar
• Rodrı́guez M, Vila-Jato JL, Torres D. Design of a new multiparticulate system for potential site specific and controlled drug delivery to the colonic region. J. Controlled Release. 1998;55:67–77.10.1016/S0168-3659(98)00029-7
   PubMed Web of Science ®Google Scholar
• Xiang-HuaQu, QWu, GQChen. In vitro study on hemocompatibility and cytocompatibility of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). J. Biomater. Sci. Polym. Ed. 2006; 17:1107–1121.10.1163/156856206778530704
   Web of Science ®Google Scholar
• Chowdhary KPR, Srinivasa RY. Design and in vitro and in vivo evaluation of mucoadhesive microcapsule of glipizide for oral controlled release: a technical note. AAPS Pharm. Sci. Tech. 2003; 4:320–325.
   Google Scholar
• Morris GD, Beck PL, Herridg MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology. 1989;96:795–803.
   PubMed Web of Science ®Google Scholar
• Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in the rat and hamster model. Gastroenterology. 1984;87:1344–1350.
   PubMed Web of Science ®Google Scholar
• Ju RTC, Nixon PR, Patel MV. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J. Pharm. Sci. 1995;84:1455–1463.10.1002/(ISSN)1520-6017
   PubMed Web of Science ®Google Scholar
• Kerbers R, Glamann H. Lösungsmitteleinflüsse auf die copolymerisations parameter des systems methylmethacrylat/acrylsäure [Solvent effects on the reactivity ratios of the system methyl methacrylate / acrylic acid]. Die Makromolekulare Chemie, German. 1967;100:290.10.1002/macp.1967.021000134
   Google Scholar
• Thakral S, Thakral NK, Majumdar DK. Eudragit®: a technology evaluation. Expert Opin. Drug Delivery. 2013;10:131–149.10.1517/17425247.2013.736962
   PubMed Web of Science ®Google Scholar
• Ito Y, Casolaro M, Kono K, et al. An insulin-releasing system that is responsive to glucose. J. Controlled Release. 1989;10:195–203.10.1016/0168-3659(89)90063-1
   Web of Science ®Google Scholar
• Autian J Biological model systems for the testing of the toxicity of biomaterials. Polymers in medicine and surgery. In: Kronethal RL, Oser Z, Martin E, editors. Polymer science and technology. New York (NY): Plenum Press; 1993. p. 181.
   Google Scholar
• Maghsoodi M. Physicomechanical properties of naproxen-loaded microparticles prepared from Eudragit L100. AAPS PharmSciTech. 2009;10:120–128.10.1208/s12249-009-9186-5
   PubMed Web of Science ®Google Scholar
• Shargel L, Yu A Applied biopharmaceutics & pharmacokinetics. London, UK: Printice-Hall International Inc.; 1999. p. 173.
   Google Scholar
• Peppas NA. Analysis of fickian and non-fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–111.
   PubMedGoogle Scholar
• Chueh HR, Zia H, Rhodes CP. Optimization of sotalol floating and bioadhesive extended release tablet formulations. Drug Dev. Ind. Pharm. 1995;21:1725–1747.10.3109/03639049509069261
   Web of Science ®Google Scholar